arrow
U

Ulrike von Arnim

department of gastroenterology, hepatology and infectious diseases, university hospital magdeburg, magdeburg, germany
H指数:27
被引数:4,429

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world-data on efficacy and safety of topical budesonide therapy (orodispersible tablet) in induction and maintenance therapy in adult patients with active eosinophilic esophagitis

关于奥洛夫可分散片(Orodispersible tablet)局部布地奈德疗法在成人活动性嗜酸性食管炎患者诱导及维持治疗中的疗效和安全性的真实世界数据

2025-10-080
OA
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension Study

Biedermann, L.; Schlag, C.; Straumann, A.; Lucendo, A.J.; Miehlke, S.; Vieth, M.; Santander, C.; Ciriza de Los Rios, C.; Schmöcker, C.; Madisch, A.; et al. 布地奈德口腔崩解片治疗嗜酸性食管炎的疗效与安全性:最长3年随访结果——一项开放标签扩展研究。Clin. Gastroenterol. Hepatol. 2024; 已接收. [Google Scholar] [CrossRef] [PubMed]

2024-12-160
OAAI
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis

临床试验: 一种新型食管给药系统局部皮质类固醇与安慰剂治疗嗜酸细胞性食管炎的安全性和有效性

2024-12-161
OAAI
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations
2023-09-0124
OAAI
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

在HBeAg阴性慢性乙型肝炎中核苷 (酸) 类似物停止的多中心随机对照试验

2023-05-0126
PRE
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature

嗜酸性胃肠道疾病命名的国际共识建议

2022-11-0191
OAAI
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
2022-02-0145
OAAI
Anti-TNFα treatment in Crohn's disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status
2021-07-219
OAAI
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis
2020-11-01120
OAAI
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial
2019-07-01195
OAAI
BUDESONIDE ORODISPERSIBLE TABLETS ARE HIGHLY EFFECTIVE FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PIVOTAL MULTICENTER TRIAL (EOS-1)
2017-04-018
PREAI
Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults
2017-04-01742
OAAI